2m 2m 2m 2m 2m 2m 2m
XBiotech (XBIT)
NASDAQ
$2.39-$0.005 (-0.21%)
Price as of Jun 03, 2026 4:10 PM EDT- $73.8MMarket Cap
- -18.71%1-Year Change
- BiotechnologyIndustry
XBiotech (XBIT)
$2.39-$0.005 (-0.21%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | 0 -100.00% | 4.0M -78.20% | |
Cost of Revenue | N/A N/A | N/A N/A | 0 -100.00% | 651,000 -88.81% | |
Gross Profit | 0 N/A | 0 N/A | 0 -100.00% | 3.4M -73.29% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -47.4M +25.51% | -37.8M +14.94% | -32.8M +4.13% | -31.5M +11.59% | |
Depreciation and Amortization Expense | 1.7M -3.38% | 1.7M +0.06% | 1.7M -33.28% | 2.6M -1.28% | |
Total Operating Expenses | 42.5M +13.23% | 37.5M 0.00% | 37.5M -0.90% | 37.8M +0.51% | |
Operating Profit | -55.7M +31.11% | -42.5M +13.23% | -37.5M +8.76% | -34.5M +37.51% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -88,000 -89.10% | -807,000 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -88,000 -89.10% | -807,000 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 10.4M +165.61% | 3.9M -70.39% | 13.2M +1,363.08% | 902,000 +339.89% | |
Income before Taxes | -45.3M +17.48% | -38.6M +58.61% | -24.3M -27.61% | -33.6M +31.93% | |
Income Taxes | 235,000 +834.38% | -32,000 -113.11% | 244,000 +135.47% | -688,000 -91.45% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -45.5M +18.19% | -38.5M +56.90% | -24.6M -25.36% | -32.9M +88.93% | |
Net Income from Continuing Operations Applicable to Common | -45.3M +17.48% | -38.6M +58.61% | -24.3M -27.61% | -33.6M +31.93% | |
Basic EPS and Net Income | -1.49 +18.25% | -1.26 +55.56% | -0.81 -25.00% | -1.08 +86.21% | |
Diluted EPS and Net Income | -1.49 +18.25% | -1.26 +55.56% | -0.81 -25.00% | -1.08 +86.21% | |
Basic Weighted Average Shares | 30.5M +0.09% | 30.5M +0.07% | 30.4M -0.003% | 30.4M +1.32% | |
Diluted Weighted Average Shares | 30.5M +0.09% | 30.5M +0.07% | 30.4M -0.003% | 30.4M +1.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 125.6M -27.29% | 172.7M -13.67% | 200.0M +27.16% | 157.3M -33.62% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 60.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 125.6M -27.29% | 172.7M -13.67% | 200.0M -8.03% | 217.5M -8.23% | |
Total Current Assets | 127.0M -27.28% | 174.6M -13.46% | 201.7M -8.24% | 219.8M -10.95% | |
Accumulated Depreciation | 21.7M +8.43% | 20.0M +9.57% | 18.2M +10.57% | 16.5M +4.86% | |
Property and Plant and Equipment and Net | 23.1M -5.70% | 24.5M -1.49% | 24.9M -5.19% | 26.3M -7.23% | |
Total Long-Term Assets | 23.1M -5.70% | 24.5M -1.49% | 24.9M -5.19% | 26.3M -7.23% | |
Total Assets | 150.1M -24.62% | 199.1M -12.14% | 226.6M -7.92% | 246.1M -10.57% | |
Income Taxes Payable | 1.9M +9.24% | 1.7M -1.83% | 1.8M +3.67% | 1.7M -28.05% | |
Total Short-Term Debt | 0 -100.00% | 10.0M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 7.9M -47.51% | 15.1M +147.62% | 6.1M +50.02% | 4.1M +17.75% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 10,000 N/A | N/A N/A | 0 -100.00% | 118,000 -93.24% | |
Total Liabilities | 9.7M -42.16% | 16.8M +116.57% | 7.8M +36.27% | 5.7M -1.57% | |
Retained Earnings | -136.4M +50.13% | -90.8M +73.66% | -52.3M +88.50% | -27.7M -638.71% | |
Total Stockholders Equity | 140.3M -23.00% | 182.3M -16.71% | 218.8M -8.97% | 240.4M -10.76% | |
Total Shares Outstanding | 30.5M 0.00% | 30.5M +0.17% | 30.4M -0.008% | 30.4M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -39.9M +28.93% | -31.0M +65.36% | -18.7M +26.32% | -14.8M -121.35% | |
Capital Expenditures | 289,000 -77.84% | 1.3M +260.22% | 362,000 -38.12% | 585,000 -83.40% | |
Cash from Investing Activities | -289,000 -77.84% | -1.3M -102.12% | 61.5M +196.25% | -63.9M +1,712.54% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash from Financing Activities | -10.3M -198.09% | 10.4M +116,211.11% | -9,000 N/A | 0 +100.00% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | 83.77% +22.54% | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -860.10% +530.76% | |
Return on Assets | -26.08% +44.10% | -18.10% +74.23% | -10.39% -17.69% | -12.62% +127.94% | |
Return on Equity | -28.23% +46.95% | -19.21% +79.65% | -10.69% -17.15% | -12.91% +129.04% | |
Revenue Growth | N/A N/A | N/A N/A | -100.00% +27.88% | -78.20% +34.38% | |
Current Ratio | 16.01 +38.54% | 11.56 -65.05% | 33.07 -38.84% | 54.07 -24.37% | |
Cash Ratio | 15.83 +38.51% | 11.43 -65.14% | 32.79 -15.24% | 38.69 -43.63% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow